研究者業績

原 嘉孝

ハラ ヨシタカ  (Hara Yoshitaka)

基本情報

所属
藤田医科大学医学部 麻酔・侵襲制御医学講座 臨床准教授
学位
博士(2017年3月 藤田医科大学)

J-GLOBAL ID
201501019556937647
researchmap会員ID
7000012998

論文

 75
  • Ken Sawada, Yasuyo Shimomura, Daisuke Hasegawa, Tatsuhiko Harada, Tomoyuki Nakamura, Naohide Kuriyama, Yoshitaka Hara, Hidefumi Komura, Osamu Nishida
    Fujita medical journal 9(2) 95-100 2023年5月  
    OBJECTIVES: Damage associated molecular patterns (DAMPs) levels are associated with sepsis severity and prognosis. Histone and high mobility group box 1 (HMGB1) levels are also potential indicators of prognosis. We investigated the relationship between serum histone H3 and HMGB1 levels and the illness severity score and prognosis in postoperative patients. METHODS: Postoperative serum histone H3 and HMGB1 levels in 39 intensive care unit (ICU) patients treated at our institution were measured. The correlation between peak histone H3 and HMGB1 levels in each patient and clinical data (age, sex, surgical time, length of ICU stay, and survival after ICU discharge), which also included the patients' illness severity score, was examined. RESULTS: Histone H3 but not HMGB1 levels were positively correlated with surgical time, the Sequential Organ Failure Assessment score, the Japanese Association for Acute Medicine acute phase disseminated intravascular coagulation diagnosis score, and the length of ICU stay. Both histone H3 and HMGB1 levels were negatively correlated with age. However, survival post-ICU discharge was not correlated with histone H3 or HMGB1 levels. CONCLUSIONS: Histone H3 levels are correlated with severity scores and the length of ICU stay. Serum histone H3 and HMGB1 levels are elevated postoperatively. These DAMPs, however, are not prognostic indicators in postoperative ICU patients.
  • Tomoyuki Nakamura, Kazuhiro Moriyama, Naohide Kuriyama, Yoshitaka Hara, Satoshi Komatsu, Takahiro Kawaji, Yu Kato, Takuma Ishihara, Ayumi Shintani, Osamu Nishida
    Membranes 12(8) 2022年8月22日  
    Blood purification is performed to control cytokines in critically ill patients. The relationship between the clearance (CL) and the membrane area during adsorption is not clear. We hypothesized that the CL increases with the hydrophobic area when hydrophobic binding contributes to cytokine adsorption. We investigated the relationship between the hemofilter membrane area and the CL of the high mobility group box 1 protein (HMGB-1) and interleukin-6 (IL-6). We performed experimental hemofiltration in vitro using polymethyl methacrylate membranes CH-1.8W (1.8 m2) and CH-1.0N (1.0 m2), as well as polysulfone membrane NV-18X (1.8 m2). After adding 100 mg of HMGB1 or 10 μg of IL-6 into the test solution, experimental hemofiltration was conducted for 360 min in a closed-loop circulation system, and the same amount of HMGB1 and IL-6 was added after 180 min. With CH-1.8W and CH-1.0N, both HMGB-1 and IL-6 showed a rapid concentration decrease of more than 70% at 180 min and 360 min after the re-addition. At 15 min, the CL of HMGB-1 was CH-1.8W: 28.4 and CH-1.0N: 19.8, and that of IL-6 was CH-1.8W: 41.1 and CH-1.0N: 25.4. CH-1.8W and CH-1.0N removed HMGB1 and IL-6 by adsorption and CH-1.8W was superior in CL, which increased with a greater membrane area.
  • Moritoki Egi, Hiroshi Ogura, Tomoaki Yatabe, Kazuaki Atagi, Shigeaki Inoue, Toshiaki Iba, Yasuyuki Kakihana, Tatsuya Kawasaki, Shigeki Kushimoto, Yasuhiro Kuroda, Joji Kotani, Nobuaki Shime, Takumi Taniguchi, Ryosuke Tsuruta, Kent Doi, Matsuyuki Doi, Taka-Aki Nakada, Masaki Nakane, Seitaro Fujishima, Naoto Hosokawa, Yoshiki Masuda, Asako Matsushima, Naoyuki Matsuda, Kazuma Yamakawa, Yoshitaka Hara, Masaaki Sakuraya, Shinichiro Ohshimo, Yoshitaka Aoki, Mai Inada, Yutaka Umemura, Yusuke Kawai, Yutaka Kondo, Hiroki Saito, Shunsuke Taito, Chikashi Takeda, Takero Terayama, Hideo Tohira, Hideki Hashimoto, Kei Hayashida, Toru Hifumi, Tomoya Hirose, Tatsuma Fukuda, Tomoko Fujii, Shinya Miura, Hideto Yasuda, Toshikazu Abe, Kohkichi Andoh, Yuki Iida, Tadashi Ishihara, Kentaro Ide, Kenta Ito, Yusuke Ito, Yu Inata, Akemi Utsunomiya, Takeshi Unoki, Koji Endo, Akira Ouchi, Masayuki Ozaki, Satoshi Ono, Morihiro Katsura, Atsushi Kawaguchi, Yusuke Kawamura, Daisuke Kudo, Kenji Kubo, Kiyoyasu Kurahashi, Hideaki Sakuramoto, Akira Shimoyama, Takeshi Suzuki, Shusuke Sekine, Motohiro Sekino, Nozomi Takahashi, Sei Takahashi, Hiroshi Takahashi, Takashi Tagami, Goro Tajima, Hiroomi Tatsumi, Masanori Tani, Asuka Tsuchiya, Yusuke Tsutsumi, Takaki Naito, Masaharu Nagae, Ichiro Nagasawa, Kensuke Nakamura, Tetsuro Nishimura, Shin Nunomiya, Yasuhiro Norisue, Satoru Hashimoto, Daisuke Hasegawa, Junji Hatakeyama, Naoki Hara, Naoki Higashibeppu, Nana Furushima, Hirotaka Furusono, Yujiro Matsuishi, Tasuku Matsuyama, Yusuke Minematsu, Ryoichi Miyashita, Yuji Miyatake, Megumi Moriyasu, Toru Yamada, Hiroyuki Yamada, Ryo Yamamoto, Takeshi Yoshida, Yuhei Yoshida, Jumpei Yoshimura, Ryuichi Yotsumoto, Hiroshi Yonekura, Takeshi Wada, Eizo Watanabe, Makoto Aoki, Hideki Asai, Takakuni Abe, Yutaka Igarashi, Naoya Iguchi, Masami Ishikawa, Go Ishimaru, Shutaro Isokawa, Ryuta Itakura, Hisashi Imahase, Haruki Imura, Takashi Irinoda, Kenji Uehara, Noritaka Ushio, Takeshi Umegaki, Yuko Egawa, Yuki Enomoto, Kohei Ota, Yoshifumi Ohchi, Takanori Ohno, Hiroyuki Ohbe, Kazuyuki Oka, Nobunaga Okada, Yohei Okada, Hiromu Okano, Jun Okamoto, Hiroshi Okuda, Takayuki Ogura, Yu Onodera, Yuhta Oyama, Motoshi Kainuma, Eisuke Kako, Masahiro Kashiura, Hiromi Kato, Akihiro Kanaya, Tadashi Kaneko, Keita Kanehata, Ken-Ichi Kano, Hiroyuki Kawano, Kazuya Kikutani, Hitoshi Kikuchi, Takahiro Kido, Sho Kimura, Hiroyuki Koami, Daisuke Kobashi, Iwao Saiki, Masahito Sakai, Ayaka Sakamoto, Tetsuya Sato, Yasuhiro Shiga, Manabu Shimoto, Shinya Shimoyama, Tomohisa Shoko, Yoh Sugawara, Atsunori Sugita, Satoshi Suzuki, Yuji Suzuki, Tomohiro Suhara, Kenji Sonota, Shuhei Takauji, Kohei Takashima, Sho Takahashi, Yoko Takahashi, Jun Takeshita, Yuuki Tanaka, Akihito Tampo, Taichiro Tsunoyama, Kenichi Tetsuhara, Kentaro Tokunaga, Yoshihiro Tomioka, Kentaro Tomita, Naoki Tominaga, Mitsunobu Toyosaki, Yukitoshi Toyoda, Hiromichi Naito, Isao Nagata, Tadashi Nagato, Yoshimi Nakamura, Yuki Nakamori, Isao Nahara, Hiromu Naraba, Chihiro Narita, Norihiro Nishioka, Tomoya Nishimura, Kei Nishiyama, Tomohisa Nomura, Taiki Haga, Yoshihiro Hagiwara, Katsuhiko Hashimoto, Takeshi Hatachi, Toshiaki Hamasaki, Takuya Hayashi, Minoru Hayashi, Atsuki Hayamizu, Go Haraguchi, Yohei Hirano, Ryo Fujii, Motoki Fujita, Naoyuki Fujimura, Hiraku Funakoshi, Masahito Horiguchi, Jun Maki, Naohisa Masunaga, Yosuke Matsumura, Takuya Mayumi, Keisuke Minami, Yuya Miyazaki, Kazuyuki Miyamoto, Teppei Murata, Machi Yanai, Takao Yano, Kohei Yamada, Naoki Yamada, Tomonori Yamamoto, Shodai Yoshihiro, Hiroshi Tanaka, Osamu Nishida
    Journal of intensive care 9(1) 53-53 2021年8月25日  査読有り
    The Japanese Clinical Practice Guidelines for Management of Sepsis and Septic Shock 2020 (J-SSCG 2020), a Japanese-specific set of clinical practice guidelines for sepsis and septic shock created as revised from J-SSCG 2016 jointly by the Japanese Society of Intensive Care Medicine and the Japanese Association for Acute Medicine, was first released in September 2020 and published in February 2021. An English-language version of these guidelines was created based on the contents of the original Japanese-language version. The purpose of this guideline is to assist medical staff in making appropriate decisions to improve the prognosis of patients undergoing treatment for sepsis and septic shock. We aimed to provide high-quality guidelines that are easy to use and understand for specialists, general clinicians, and multidisciplinary medical professionals. J-SSCG 2016 took up new subjects that were not present in SSCG 2016 (e.g., ICU-acquired weakness [ICU-AW], post-intensive care syndrome [PICS], and body temperature management). The J-SSCG 2020 covered a total of 22 areas with four additional new areas (patient- and family-centered care, sepsis treatment system, neuro-intensive treatment, and stress ulcers). A total of 118 important clinical issues (clinical questions, CQs) were extracted regardless of the presence or absence of evidence. These CQs also include those that have been given particular focus within Japan. This is a large-scale guideline covering multiple fields; thus, in addition to the 25 committee members, we had the participation and support of a total of 226 members who are professionals (physicians, nurses, physiotherapists, clinical engineers, and pharmacists) and medical workers with a history of sepsis or critical illness. The GRADE method was adopted for making recommendations, and the modified Delphi method was used to determine recommendations by voting from all committee members.As a result, 79 GRADE-based recommendations, 5 Good Practice Statements (GPS), 18 expert consensuses, 27 answers to background questions (BQs), and summaries of definitions and diagnosis of sepsis were created as responses to 118 CQs. We also incorporated visual information for each CQ according to the time course of treatment, and we will also distribute this as an app. The J-SSCG 2020 is expected to be widely used as a useful bedside guideline in the field of sepsis treatment both in Japan and overseas involving multiple disciplines.
  • Yoshitaka Hara, Tomoaki Yatabe, Koshiro Kikkawa, Tomoyuki Nakamura, Naohide Kuriyama, Osamu Nishida
    Journal of artificial organs : the official journal of the Japanese Society for Artificial Organs 2021年8月16日  
    Infection during extracorporeal membrane oxygenation (ECMO) is a common complication that leads to increased mortality. Thus, antimicrobial prophylaxis during ECMO is often performed to prevent of nosocomial infections. However, the current status of antimicrobial prophylaxis during ECMO in Japan is unclear. Therefore, we conducted a national survey of members of the Japanese Society of Intensive Care Medicine (JSICM) to clarify the current status of antimicrobial prophylaxis during ECMO in intensive care units. An 11-question survey was devised to assess antimicrobial prophylaxis and surveillance practices during ECMO. A total of 253 hospitals responded. Of these, 235 hospitals were the JSICM-certified hospitals, and the response rate was 64%. A total of 96 hospitals (39%) administered antimicrobial prophylaxis during ECMO, and 17% of hospitals had a standardized protocol for antimicrobial prophylaxis during ECMO. Of these 96 hospitals, 79% used single agents. First-generation cephalosporins were the most commonly used (54%), followed by penicillins or penicillin-derived combinations (24%), second-generation cephalosporins (7%), and anti-methicillin-resistant Staphylococcus aureus agents (6%). In conclusion, our survey revealed 39% of hospitals administered antimicrobial prophylaxis during ECMO in Japan. First-generation cephalosporins were the agents most commonly used.
  • Shinya Suzuki, Kazuhiro Moriyama, Yoshitaka Hara, Takuya Hinoue, Yu Kato, Daisuke Hasegawa, Naohide Kuriyama, Tomoyuki Nakamura, Satoshi Komatsu, Chizuru Yamashita, Hidefumi Komura, Osamu Nishida
    Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy 25(4) 401-406 2021年8月  
    Myoglobin, which can cause acute kidney injury, has a relatively high molecular weight and is poorly cleared by diffusion. We compared and examined myoglobin clearance by changing the blood purification membrane and modality in patients with a myoglobin blood concentration ≥ 1000 ng/ml. We retrospectively analyzed three patient groups based on the following three types of continuous hemofiltration (CHF): AN69ST membrane, polymethylmethacrylate (PMMA) membrane, and high-flow hemodiafiltration (HDF) with increased dialysate flow rate using the PMMA membrane. There was no significant difference in clearance in CHF between AN69ST and PMMA membranes. However, the high-flow HDF group showed the highest myoglobin clearance (p = 0.003). In the PMMA membrane, changing the treatment modality to high-flow HDF increased clearance above the theoretical value, possibly due to internal filtration. To remove myoglobin by kidney replacement therapy from patients with hypermyoglobinemia, a modality such as high-flow HDF would be desirable.
  • Takuya Hinoue, Isao Nahara, Tomoaki Yatabe, Yoshitaka Hara, Naohide Kuriyama, Tomoyuki Nakamura, Hidefumi Komura, Osamu Nishida
    Journal of cardiothoracic and vascular anesthesia 2021年7月8日  
    OBJECTIVES: Hyperchloremia is a potential risk factor for acute kidney injury (AKI) in critically ill patients. However, the relationship between hyperchloremia and postoperative AKI in adult patients undergoing cardiovascular surgery with cardiopulmonary bypass (CPB) remains unclear. The authors aimed to determine whether postoperative hyperchloremia was associated with postoperative AKI in these populations. OBJECTIVES: Retrospective, single-center study. SETTING: Tertiary care hospital. PARTICIPANTS: Adult patients who underwent cardiovascular surgery with CPB. INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: Patients with and without postoperative hyperchloremia were matched (1:1). The primary outcome was the rate of postoperative AKI diagnosed using the Kidney Disease: Improving Global Outcomes consensus criteria. Postoperative hyperchloremia was defined as postoperative serum chloride levels of >110 mmol/L during the first 48 hours. An increase in serum chloride levels (Δ[Cl-]) was defined as the difference between the preoperative and maximum postoperative serum chloride levels during the first 48 hours ([Cl-]max). Propensity-score matching and univariate and multivariate logistic regression analyses were employed. A total of 323 patients were included. Propensity-score matching selected 55 pairs for the final comparison. The incidence of postoperative AKI did not differ between the two groups (47% v 46%, p = 1.0). In the multivariate logistic regression analysis, Δ[Cl-] was associated independently with the development of postoperative AKI (odds ratio, 1.13; 95% confidence interval, 1.06-1.21; p < 0.001). CONCLUSIONS: Exposure to postoperative hyperchloremia was not associated with postoperative AKI in adult patients undergoing cardiovascular surgery with CPB. However, an increase in the serum chloride level might be associated with postoperative AKI.
  • Yoshitaka Hara, Tomoaki Yatabe, Satoshi Komatsu, Naohide Kuriyama, Tomoyuki Nakamura, Chizuru Yamashita, Hidefumi Komura, Osamu Nishida
    Journal of artificial organs : the official journal of the Japanese Society for Artificial Organs 24(2) 282-286 2021年6月  
    Spontaneous abdominal wall hematomas are relatively rare and mainly attributed to anticoagulation and severe cough. Despite the high incidence of anticoagulation-related bleeding complications, there are no reports of spontaneous abdominal wall hematomas during extracorporeal membrane oxygenation (ECMO). We report a case of a spontaneous rectus sheath hematoma caused by alternation of the lateral semi-prone position during ECMO in a 76-year-old female patient with severe acute respiratory distress syndrome. Unfractionated heparin 12,000-14,000 units/day was administered for anticoagulation during ECMO. From Day 6 of ECMO, the patient who was under deep sedation was alternately placed in the left and right lateral semi-prone positions every 4 h, for approximately 20 h per day. On Day 12 of ECMO, the patient developed hypotension with anemia and a palpable mass in the right lower abdomen. Abdominal ultrasonographic imaging revealed a huge echo-free space centered in the right lower abdomen. Emergency contrast-enhanced computed tomography (CT) scanning showed extravasation from the superior and inferior epigastric arteries as well as a rectus sheath hematoma. Despite no apparent contrast leakage, an inferior epigastric artery embolization was undertaken because the patient was on ECMO. On Day 13 after ECMO initiation, ECMO and anticoagulation were discontinued. On CT scanning a week later, the hematoma had reduced. In conclusion, spontaneous abdominal wall hematoma is a rare and important complication that might occur during ECMO. Thus, careful physical examination should be routinely conducted when the patient is semi-prone during ECMO.
  • Kazuma Yamakawa, Ryo Yamamoto, Go Ishimaru, Hideki Hashimoto, Takero Terayama, Yoshitaka Hara, Daisuke Hasegawa, Tadashi Ishihara, Haruki Imura, Hiromu Okano, Chihiro Narita, Takuya Mayumi, Hideto Yasuda, Kohei Yamada, Hiroyuki Yamada, Tatsuya Kawasaki, Nobuaki Shime, Kent Doi, Moritoki Egi, Hiroshi Ogura, Morio Aihara, Hiroshi Tanaka, Osamu Nishida
    Acute medicine & surgery e664 2021年5月4日  
    The Coronavirus disease 2019 (COVID-19) has spread worldwide since early 2020, and there are still no signs of resolution. The Japanese Clinical Practice Guidelines for the Management of Sepsis and Septic Shock (J-SSCG) 2020 Special Committee created the Japanese Rapid/Living recommendations on drug management for COVID-19 using the experience of creating the J-SSCGs. The Grades of Recommendation, Assessment, Development, and Evaluation (GRADE) approach was used to determine the certainty of the evidence and strength of the recommendations. The first edition of this guideline was released on September 9, 2020, and this document is the revised edition (ver. 3.1) (released on March 30, 2021). Clinical questions (CQs) were set for the following seven drugs: favipiravir (CQ1), remdesivir (CQ-2), hydroxychloroquine (CQ-3), corticosteroids (CQ-4), tocilizumab (CQ-5), ciclesonide (CQ-6), and anticoagulants (CQ-7). Favipiravir is recommended for patients with mild COVID-19 not requiring supplemental oxygen (GRADE 2C); remdesivir for moderate COVID-19 patients requiring supplemental oxygen/hospitalization (GRADE 2B); hydroxychloroquine is not recommended for all COVID-19 patients (GRADE 1B); corticosteroids are recommended for moderate COVID-19 patients requiring supplemental oxygen/hospitalization (GRADE 1B) and severe COVID-19 patients requiring ventilator management/intensive care (GRADE 1A); however, their administration is not recommended for mild COVID-19 patients not requiring supplemental oxygen (GRADE 1B); tocilizumab is recommended for moderate COVID-19 patients requiring supplemental oxygen/hospitalization (GRADE 2B); and anticoagulant therapy for moderate COVID-19 patients requiring supplemental oxygen/hospitalization and severe COVID-19 patients requiring ventilator management/intensive care (GRADE 2C). We hope that these clinical practice guidelines will aid medical professionals involved in the care of COVID-19 patients.
  • 福島 美奈子, 山下 千鶴, 古賀 恵里, 宇都宮 志織, 幸村 英文, 柴田 純平, 中村 智之, 栗山 直英, 原 嘉孝, 西田 修
    麻酔 70(4) 425-430 2021年4月  
  • Daisuke Hasegawa, Kazuki Nishida, Takahiro Kawaji, Yoshitaka Hara, Yasuyo Shimomura, Kazuhiro Moriyama, Daisuke Niimi, Naohide Kuriyama, Ayumi Shintani, Hidefumi Komura, Osamu Nishida
    Diagnostics (Basel, Switzerland) 10(10) 2020年10月15日  
    ABO blood groups have been implicated as potential risk factors for various diseases. However, no study has investigated the association between sepsis mortality and ABO blood types. We aimed to evaluate the impact of these blood types on mortality in patients with sepsis and septic shock. This retrospective observational study was conducted at two general hospitals in Japan. Patients diagnosed with sepsis or septic shock were included and divided into four groups based on blood type (O, A, B, and AB). The association between type O vs. other types and 28- and 90-day mortalities was evaluated using multivariate logistic regression analysis adjusted for age, sex, and Sequential (Sepsis-related) Organ Failure Assessment score. This study included 415 patients, of whom 131 (31.6%), 171 (41.2%), 81 (19.5%), and 32 (7.7%) had type O, A, B, and AB, respectively. Blood type O was not associated with 28-day (odds ratio: 1.7 p = 0.08) or 90-day mortality (odds ratio: 1.53, p = 0.091). However, type O was significantly associated with higher 90-day mortality (odds ratio: 3.26, p = 0.009) in patients with septic shock. The role of ABO blood type in risk stratification for septic shock and the mechanisms that potentially affect the prognosis of sepsis patients need further investigation.
  • Naohide Kuriyama, Kana Matsumoto, Kunihiko Morita, Yasuyo Shimomura, Yoshitaka Hara, Daisuke Hasegawa, Tomoyuki Nakamura, Chizuru Yamashita, Yu Kato, Hidefumi Komura, Osamu Nishida
    Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy 24(5) 499-502 2020年10月  
    Patients who undergo renal replacement therapy often exhibit a high plasma linezolid concentration. Linezolid is metabolized via oxidation. Nafamostat mesilate has antioxidant effects and is frequently used as an anticoagulant during renal replacement therapy. We aimed to investigate the effect of nafamostat mesilate on plasma linezolid concentration. We examined whether the co-administration of linezolid and nafamostat had any effect on plasma linezolid concentration. Mice were randomly allocated to two groups (n = 18/group): linezolid (100 mg kg-1 , subcutaneous injection) + nafamostat (30 mg kg-1 , intraperitoneal injection) and linezolid + saline. At 5 hours, the linezolid concentration was significantly higher in the linezolid + nafamostat co-administration group than that in the linezolid + saline group (20.6 ± 9.8 vs 3.6 ± 1.2 μg/mL, respectively P < .001). The antioxidant effects of nafamostat may inhibit linezolid metabolism, resulting in the adverse event of high linezolid concentration if both are administered concurrently during renal replacement therapy.
  • Tomoyuki Nakamura, Takahiro Kawaji, Tatsuhiko Harada, Yu Kato, Kazuhiro Moriyama, Daisuke Hasegawa, Hidefumi Komura, Junpei Shibata, Chizuru Yamashita, Naohide Kuriyama, Yoshitaka Hara, Osamu Nishida
    Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy 24(5) 476-481 2020年10月  
    We aimed to evaluate whether cardiac output assessed by transpulmonary thermodilution during blood purification is affected by the difference between the blood return temperature and core temperature. We applied different blood return temperatures using a thermostat bath during blood purification in four pigs. After the blood return temperature stabilized and blood purification process stopped, the cardiac output assessed by transpulmonary thermodilution was measured. The thermostat bath was set at 35°C, 40°C, 45°C, and 50°C, with the order changed at random; four measurements were made at each temperature. Cardiac function was evaluated by echocardiography when ice-cold saline was administered in a pig. A decrease in the blood return temperature resulted in decreased cardiac output assessed by transpulmonary thermodilution, whereas an increase resulted in increased cardiac output assessed by transpulmonary thermodilution. Echocardiography revealed that the change in the blood return temperature did not affect the left ventricular ejection fraction.
  • Nakamura T, Moriyama K, Shimomura Y, Kato Y, Kuriyama N, Hara Y, Tamada Y, Nishida O
    Tharapeautic Apheresis and Dialysis 2020年3月26日  査読有り
  • Hiraiwa T, Moriyama K, Matsumoto K, Shimomura Y, Kato Y, Yamashita C, Hara Y, Kawaji T, Kurimoto Y, Nakamura T, Kuriyama N, Shibata J, Komura H, Morita K, Nishida O
    Blood Purification 1-7 2020年2月  査読有り
  • Mariko Nagata, Yoshitaka Hara, Seiko Hayakawa, Hidefumi Komura, Junpei Shibata, Chizuru Yamashita, Tomoyuki Nakamura, Naohide Kuriyama, Sohta Uchiyama, Kotaro Kawata, Osamu Nishida
    Fujita medical journal 6(3) 59-66 2020年  
    OBJECTIVES: Hepatectomy is used to treat several liver diseases, although perioperative mortality and postoperative complication rates remain high. Given the lack of relevant studies to date, the present study aimed to investigate potential predictive factors for postoperative complications in patients undergoing hepatectomies lasting 12 or more hours (termed "extremely long hepatectomies"). METHODS: Adult patients undergoing treatment in the intensive care unit (ICU) after extremely long hepatectomies at Fujita Health University Hospital between 2014 and 2017 were enrolled in the study. Postoperative complications were classified as "major complications" and "non-major complications" according to the Clavien-Dindo Classification grading system. We also divided our study population into "simple hepatectomy" and "non-simple hepatectomy" subgroups for further analysis. Statistical analyses were performed using the Mann-Whitney U test, chi-squared test, and multiple logistic regression analysis. RESULTS: In total, 114 patients (Major Complications Group, n=44; Non-Major Complications Group, n=70) were enrolled. In the Simple Hepatectomy Group, there were no significant variables. In the Non-Simple Hepatectomy Group, female sex (odds ratio [OR], 13.4; 95% confidence interval [CI], 1.00-1.81×102; p=0.04) and lactate levels at ICU admission (OR, 1.6; 95% CI, 0.99-2.59; p=0.05) were independent factors associated with major postoperative complications. CONCLUSIONS: In the Simple Hepatectomy Group, there were no significant variables. In the Non-Simple Hepatectomy Group, female sex and lactate levels at ICU admission of patients who underwent extremely long hepatectomies may be independent factors associated with major postoperative complications.
  • 竹本雄一, 森山和広, 山下千鶴, 原嘉孝, 西田修
    日急性血浄化会誌 10(2) 106-110 2019年12月  査読有り
  • Kurimoto Y, Shimomura Y, Moriyama K, Nakamura T, Kuriyama N, Hara Y, Komura H, Hasegawa D, Kawaji T, Nishida O
    Fujita Medical Journal. 1-5 2019年11月  査読有り
  • Hasegawa D, Nishida K, Hara Y, Kawaji T, Moriyama K, Shimomura Y, Niimi D, Komura H, Nishida O
    J Intensive Care 7(2) DOI.org/10.1186/s40560-019-03 2019年6月  査読有り
  • 原 嘉孝, 幸村 英文, 樋上 拓哉, 鷲見 弘文, 勝田 賢, 秋山 正慶, 早川 聖子, 内山 壮太, 森山 和広, 西田 修
    日本集中治療医学会雑誌 26(Suppl.) [O57-6] 2019年2月  
  • Keita Muramatsu, Koichiro Matsuo, Yusuke Kawai, Tsukasa Yamamoto, Yoshitaka Hara, Yasuyo Shimomura, Chizuru Yamashita, Osamu Nishida
    Japan journal of nursing science : JJNS 16(1) 80-87 2019年1月  
    AIM: Endotracheal intubation of critically ill patients increases the risk of aspiration pneumonia, which can be reduced by regular oral care. However, the rinsing of the residual oral contaminants after mechanical cleaning carries the risk of aspirating the residue during the intubation period. Removing the contaminants by wiping with mouth wipes could be an alternative to rinsing with water because of no additional fluid. This study tested: (i) the amount of oral bacteria during endotracheal intubation and after extubation; and (ii) the changes in the bacterial count during oral care procedures. METHODS: Thirty-five mechanically ventilated patients in the intensive care unit were enrolled. The amount of bacteria on the dorsal tongue surface was counted before and following oral care and then after the elimination of contaminants either by rinsing with water and suctioning or by wiping with mouth wipes. The oral bacterial amount was compared statistically between the intubation and extubation status and among set time points during the oral care procedure. RESULTS: The oral bacterial count was significantly decreased after extubation. During the oral care procedure, the oral bacterial amount was significantly lower after eliminating the contaminants either by rinsing or wiping, with no remarkable difference between the elimination techniques. CONCLUSIONS: The findings suggest that the oral bacterial amount is elevated during endotracheal intubation, which could increase the risk of aspiration pneumonia. The significant reduction in the bacterial count by wiping indicates that it might be a suitable alternative to rinsing for mechanically ventilated patients.
  • Satoshi Komatsu, Yoshitaka Hara, Naohide Kuriyama, Tomoyuki Nakamura, Chizuru Yamashita, Hidefumi Komura, Junpei Shibata, Osamu Nishida
    Fujita medical journal 5(4) 104-106 2019年  
    OBJECTIVES: Nasal high-flow (NHF) therapy provides continuous positive airway pressure (CPAP), flushes the anatomical dead space, and improves mucociliary clearance. CPAP is usually applied at a flow rate at or above an established threshold value with the mouth closed because it is hard to maintain it with an open mouth. We conducted a prospective study to validate our hypothesis that CPAP can be applied with the mouth open through a surgical face mask. METHODS: We inserted 12-Fr nasogastric tubes through the noses of 18 healthy individuals and fixed each tube within the pharynx to monitor the intrapharyngeal pressure. We monitored the pressure during the following two conditions: NHF oxygen with the mouth open (condition O) and NHF oxygen with the mouth open and wearing a surgical face mask (condition OM). We set the NHF rate at 40 L/min and the oxygen concentration at 21%, under all conditions. We measured the intrapharyngeal pressure five times during each inspiration and expiration, and calculated mean values. RESULTS: The mean expiratory intrapharyngeal pressure (median [interquartile range]) increased significantly from the baseline during conditions O (2.08 [1.58-4.02] cm H2O) and OM (3.35 [2.72-3.79] cm H2O). In addition, there was a significant difference in pressure between conditions O and OM (p=0.0263, Wilcoxon signed-rank test). CONCLUSIONS: In our healthy volunteers, the intrapharyngeal pressures increased during expiration with an open mouth while wearing a surgical face mask.
  • Tomoaki Yatabe, Shigeaki Inoue, So Sakamoto, Yuka Sumi, Osamu Nishida, Kei Hayashida, Yoshitaka Hara, Tatsuma Fukuda, Asako Matsushima, Akihisa Matsuda, Hideto Yasuda, Kazuto Yamashita, Moritoki Egi
    Thrombosis Research 171 136-142 2018年11月  査読有り
  • 矢田部 智昭, 西田 修, 小倉 裕司, 井上 茂亮, 江木 盛時, 近藤 豊, 坂本 壮, 櫻谷 正明, 原 嘉孝, 福田 龍将, 松嶋 麻子, 安田 英人, 山川 一馬, 山下 和人, 日本版敗血症診療ガイドライン2016作成特別委員会アンケート調査実施班
    日本救急医学会雑誌 29(10) 322-322 2018年10月  
  • 山下千鶴, 森山和広, 長谷川大祐, 原嘉孝, 西田修
    日外感染症会誌 . (15) 216-220 2018年10月  査読有り招待有り
  • Yamashita C, Moriyama K, Hasegawa D, Hara Y, Kuriyama N, Nakamura T, Shibata J, Komura H, Nishida O
    Recent Advances in Dialysis Therapy in Japan Karger Publishers. 196 215-222 2018年7月  査読有り
  • Takahiro Kawaji, Toshikazu Sakai, Kazuhiro Moriyama, Yoshitaka Hara, Tomoyuki Nakamura, Naohide Kuriyama, Yasuyo Shimomura, Yu Kato, Hidefumi Komura, Chizuru Yamashita, Yasuyoshi Kurimoto, Daisuke Hasegawa, Osamu Nishida
    Therapeutic Apheresis and Dialysis 22(3) 290-294 2018年5月  査読有り招待有り
  • 清水 弘太, 原 嘉孝, 勝田 賢, 柳 明男, 早川 聖子, 河田 耕太郎, 内山 壮太, 中村 智之, 石川 隆志, 西田 修
    日本集中治療医学会雑誌 25(Suppl.) [O34-2] 2018年2月  
  • 山下千鶴, 西田修, 原嘉孝, 栗山直英, 中村智之, 柴田純平, 幸村英文, 森山和広
    日本急性血液浄化学会雑誌 8(2) 113-117 2017年12月  査読有り招待有り
  • 栗本 恭好, 原 嘉孝, 川治 崇泰, 早川 聖子, 中村 智之, 幸村 英文, 山下 千鶴, 柴田 純平, 西田 修
    日本急性血液浄化学会雑誌 8(1) 48-53 2017年6月  
  • 原 嘉孝, 中村 藍, 竹田 彩香, 栗本 恭好, 山添 泰佳, 磯部 恵里, 勝田 賢, 川治 崇泰, 栗山 直英, 西田 修
    日本集中治療医学会雑誌 24(Suppl.) SY1-3 2017年2月  
  • 勝田 賢, 原 嘉孝, 柴田 純平, 鷲見 弘文, 笠井 美奈, 高木 沙央里, 小松 聖史, 内山 壮太, 栗山 直英, 西田 修
    日本集中治療医学会雑誌 24(Suppl.) O28-4 2017年2月  
  • 樋上 拓哉, 川治 崇泰, 早川 聖子, 勝田 賢, 高木 沙央里, 柳 明男, 小松 聖史, 原 嘉孝, 山下 千鶴, 西田 修
    日本集中治療医学会雑誌 24(Suppl.) DP97-4 2017年2月  
  • 柳 明男, 原 嘉孝, 内山 壮太, 前田 隆求, 小松 聖史, 早川 聖子, 柴田 純平, 西田 修
    日本集中治療医学会雑誌 24(4) 412-416 2017年  
    腸管出血性大腸菌(enterohemorrhagic Escherichia coli, EHEC)感染による溶血性尿毒症症候群(hemolytic uremic syndrome, HUS)に対する血漿交換療法(plasma exchange, PE)の有用性は不明である。一方,中枢神経症状発症時期と腎機能障害の関係を示した報告はほとんどない。今回,当院ICUに入室しPEを施行したEHEC感染によるHUSの小児2例,PEを施行しなかったEHECによるHUSの小児1例の経過について腎機能の推移を含め報告する。対象は当院ICUへ入室したEHECによるHUS患児3例。入室時に全例で無尿を認め,持続的血液透析濾過(continuous hemodiafiltration, CHDF)を開始。中枢神経系(central nervous system, CNS)障害を認めた2例に対し,消化器症状発症からそれぞれ9,10日目にPEを3日間施行。2例とも退室時にCNS障害を認めず,CHDF期間はそれぞれ9,13日間であった。CNS障害を認めなかったPE非施行例のCHDF期間は36日間であった。
  • 新美 太祐, 秋山 正慶, 原 嘉孝, 中村 智之, 栗山 直英, 山下 千鶴, 柴田 純平, 西田 修
    日本集中治療医学会雑誌 24(1) 37-38 2017年  
  • Toshikazu Sakai, Yoshitaka Hara, Yu Kato, Tomoyuki Nakamura, Yasuyo Shimomura, Takahiro Kawaji, Yasuyoshi Kurimoto, Mariko Nagata, Seiko Hayakawa, Hidefumi Komura, Chizuru Yamashita, Junpei Shibata, Kazuhiro Moriyama, Osamu Nishida
    Fujita Medical Journal 2(4) 73-76 2016年11月  査読有り
  • 江木 盛時, 井上 茂亮, 角 由佳, 林田 敬, 原 嘉孝, 福田 龍将, 松田 明久, 安田 英人, 矢田部 智昭, 山川 一馬, 山下 和人, 松嶋 麻子, 坂本 壮, 射場 敏明, 今泉 均, 垣花 泰之, 久志本 成樹, 小谷 穣治, 貞広 智仁, 志馬 伸朗, 中川 聡, 中田 孝明, 布宮 伸, 林 淑朗, 藤島 清太郎, 升田 好樹, 松田 直之, 小倉 裕司, 西田 修, 織田 成人, 田中 裕, 日本版敗血症診療ガイドライン2016作成特別委員会
    日本救急医学会雑誌 27(9) 301-301 2016年9月  
  • 久志本 成樹, 垣花 泰之, 松嶋 麻子, 松田 明久, 福田 龍将, 井上 茂亮, 射場 敏明, 今泉 均, 江木 盛時, 小倉 裕司, 小谷 穣治, 坂本 壮, 貞広 智仁, 志馬 伸朗, 角 由佳, 林田 敬, 原 嘉孝, 中川 聡, 中田 孝明, 布宮 伸, 林 淑朗, 藤島 清太郎, 升田 好樹, 松田 直之, 安田 英人, 矢田部 智昭, 山下 和人, 西田 修, 織田 成人, 田中 裕, 日本版敗血症診療ガイドライン2016作成特別委員会
    日本救急医学会雑誌 27(9) 303-303 2016年9月  
  • 栗本 恭好, 原 嘉孝, 川治 崇泰, 大槻 藍, 若子 尚子, 山添 泰佳, 竹田 彩香, 磯部 恵里, 勝田 賢, 高木 沙央里, 柳 明男, 小松 聖史, 早川 聖子, 河田 耕太郎, 内山 壮太, 中村 智之, 幸村 英文, 山下 千鶴, 柴田 純平, 西田 修
    日本急性血液浄化学会雑誌 7(Suppl.) 76-76 2016年9月  
  • 早川聖子, 西田修, 中村智之, 原嘉孝, 山下千鶴, 柴田純平, 新美太祐, 河田耕太郎, 内山 壮太, 秋山正慶, 小松聖史, 前田隆求, 柳明男, 高木沙央里, 森山和広, 岡本晃直
    日本急性血液浄化学会雑誌 7(1) 72-75 2016年6月  査読有り
  • 山川 一馬, 西田 修, 小倉 裕司, 江木 盛時, 松嶋 麻子, 井上 茂亮, 角 由佳, 林田 敬, 福田 龍将, 安田 英人, 原 嘉孝, 松田 明久, 矢田部 智昭, 山下 和人, 坂本 壮, 近藤 豊, 櫻谷 正明, 射場 敏明, 今泉 均, 垣花 泰之, 久志本 成樹, 小谷 穣治, 貞広 智仁, 志馬 伸朗, 中川 聡, 中田 孝明, 布宮 伸, 林 淑朗, 藤島 清太郎, 升田 好樹, 松田 直之, 織田 成人, 田中 裕, 日本版重症敗血症診療ガイドライン2016作成特別委員会
    日本集中治療医学会雑誌 23(Suppl.) 325-325 2016年1月  
  • 川治 崇泰, 原 嘉孝, 大槻 藍, 山添 泰佳, 勝田 賢, 小松 聖史, 秋山 正慶, 内山 壮太, 柴田 純平, 西田 修
    日本集中治療医学会雑誌 23(Suppl.) 506-506 2016年1月  
  • 川治 崇泰, 原 嘉孝, 加藤 大貴, 内山 壮太, 河田 耕太郎, 早川 聖子, 栗山 直英, 中村 智之, 下村 泰代, 山下 千鶴, 西田 修
    日本静脈経腸栄養学会雑誌 31(1) 257-257 2016年1月  
  • Kato Yu, Shimomura Yasuyo, Nagao Shizuko, Suga Mika, Kuriyama Naohide, Nakamura Tomoyuki, Hara Yoshitaka, Nishida Osamu
    CRITICAL CARE MEDICINE 43(12) 2015年12月  査読有り
  • 加藤 大貴, 下村 泰代, 川治 崇泰, 早川 聖子, 原 嘉孝, 中村 智之, 柴田 純平, 西田 修
    日本臨床麻酔学会誌 35(6) S245-S245 2015年10月  
  • 原 嘉孝, 早川 聖子, 大槻 藍, 若子 尚子, 山添 泰佳, 竹田 彩香, 磯部 恵里, 勝田 賢, 川治 崇泰, 高木 沙央里, 柳 明男, 前田 隆求, 小松 聖史, 河田 耕太郎, 内山 壮太, 新美 太祐, 中村 智之, 山下 千鶴, 柴田 純平, 西田 修
    日本急性血液浄化学会雑誌 6(Suppl.) 60-60 2015年9月  
  • 江木 盛時, 井上 茂亮, 角 由佳, 林田 敬, 原 嘉孝, 福田 龍将, 松田 明久, 安田 英人, 矢田部 智昭, 山下 和人, 松嶋 麻子, 坂本 壮, 射場 敏明, 今泉 均, 垣花 泰之, 久志本 成樹, 小谷 穣治, 貞広 智仁, 志馬 伸朗, 中川 聡, 中田 孝明, 布宮 伸, 林 淑朗, 藤島 清太郎, 升田 好樹, 松田 直之, 小倉 裕司, 西田 修, 織田 成人, 田中 裕, 日本版重症敗血症診療ガイドライン2016作成特別委員会
    日本救急医学会雑誌 26(8) 312-312 2015年8月  
  • Chizuru Yamashita, Yoshitaka Hara, Naohide Kuriyama, Tomoyuki Nakamura, Osamu Nishida
    THERAPEUTIC APHERESIS AND DIALYSIS 19(4) 316-323 2015年8月  査読有り
  • Yoshitaka Hara, Yasuyo Shimomura, Tomoyuki Nakamura, Naohide Kuriyama, Chizuru Yamashita, Yu Kato, Taku Miyasho, Toshikazu Sakai, Shingo Yamada, Kazuhiro Moriyama, Osamu Nishida
    Therapeautic Apheresis and Dialysis 19(4) 308-315 2015年8月  査読有り
  • 福島 美奈子, 山下 千鶴, 前田 隆求, 小松 聖史, 河田 耕太郎, 伊藤 舞, 早川 聖子, 原 嘉孝, 石川 清仁, 西田 修
    日本集中治療医学会雑誌 21(Suppl.) [DP-3] 2014年1月  
  • 山下 千鶴, 西田 修, 前田 隆求, 原 嘉孝, 中村 智之, 早川 聖子, 小松 聖史, 栗山 直英
    ICUとCCU 37(12) 897-903 2013年12月  

MISC

 94

書籍等出版物

 9

講演・口頭発表等

 158

共同研究・競争的資金等の研究課題

 1